Bluejay Diagnostics Inc.

NASDAQ: BJDX · Real-Time Price · USD
1.36
0.05 (3.82%)
At close: Aug 15, 2025, 3:58 PM
1.38
1.10%
After-hours: Aug 15, 2025, 07:56 PM EDT

Bluejay Diagnostics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 216.09K n/a n/a n/a 1.45M n/a n/a n/a n/a n/a 249.04K n/a n/a n/a n/a n/a
Cost of Revenue
38.35K 51.89K 108.04K 53.57K 53.72K 54.33K 56.32K 270.79K 293.5K 160.34K 68.92K 86.68K 200.13K 68.21K 39.21K 42K 23.67K n/a
Gross Profit
-38.35K -51.89K 108.04K -53.57K -53.72K -54.33K 1.39M -270.79K -293.5K -160.34K -68.92K -86.68K 48.91K -68.21K -39.21K -42K -23.67K n/a
Operating Income
-1.99M -1.89M -1.48M -1.36M -1.9M -2.43M -2.39M -2.34M -2.9M -2.84M -2.45M -2.81M -1.99M -2.07M -1.37M -957.99K -666.07K -233.2K
Interest Income
29.25K 17.8K 145.82K n/a n/a 30.09K 164.9K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-1.96M -1.86M -1.43M -1.48M -2.48M -2.33M -2.3M -2.3M -2.81M -2.54M -2.39M -2.96M -1.94M -2.01M -1.46M -1.19M -640.23K -194.19K
Net Income
-1.96M -1.86M -1.43M -1.48M -2.48M -2.33M -2.3M -2.3M -2.81M -2.24M -2.37M -3.23M -1.94M -1.95M -1.46M -1.19M -640.23K -194.19K
Selling & General & Admin
1.1M 1.1M 930.65K 809.95K 862.79K 1.09M 1.1M 943.91K 1.23M 1.33M 1.13M 1.43M 1.28M 1.37M 917.65K 515.46K 440.08K 209.01K
Research & Development
889.9K 784.8K 554K 551.65K 1.03M 1.33M 1.29M 1.4M 1.68M 1.35M 1.32M 1.38M 756.28K 694.76K 455.25K 442.53K 225.99K 24.18K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a 90.38K 139.73K 94.55K 60.41K n/a 54.86K 5.32K 2.04K 10.01K 848.00
Operating Expenses
1.99M 1.89M 1.48M 1.36M 1.9M 2.43M 2.39M 2.34M 2.9M 2.68M 2.45M 2.81M 2.03M 2.07M 1.37M 957.99K 591.07K 233.2K
Interest Expense
222.00 n/a 729.00 190.61K 626.47K n/a 300.07K n/a 336.00 n/a n/a 149.71K n/a n/a 97.91K 237.43K n/a n/a
Selling & Marketing Expenses
n/a n/a 816.00 753.00 305.00 6.42K 687.00 -19.62K 154.33K 148.05K 170.28K 146.1K 81.36K 53.69K 99.96K 70.41K 50.25K 69.1K
Cost & Expenses
1.99M 1.89M 1.48M 1.36M 1.9M 2.43M 2.39M 2.34M 2.9M 2.68M 2.45M 2.81M 2.23M 2.07M 1.37M 957.99K 591.07K 233.2K
Income Tax Expense
n/a n/a n/a n/a n/a 4.00 -3 n/a n/a -300.07K -19.34K 273.15K n/a -68.21K n/a n/a n/a n/a
Shares Outstanding (Basic)
1.39M 160.23K 160.23K 160.23K 148.65K 148.65K 154.89K 137.87K 127.88K 127.34K 126.3K 125.95K 125.95K 125.89K 125.7K 121.89K 105.04K 78.68K
Shares Outstanding (Diluted)
1.39M 160.23K 160.23K 160.23K 148.65K 148.65K 154.89K 137.87K 127.88K 127.34K 126.3K 125.95K 125.95K 125.89K 125.7K 121.89K 105.04K 78.68K
EPS (Basic)
-1.41 -11.64 -8.94 -9.25 -16.65 -15.66 -14.87 -16.67 -22 -17.59 -18.74 -25.67 -15.38 -15.45 -11.62 -9.79 -6.09 -2.47
EPS (Diluted)
-1.41 -11.64 -8.94 -9.25 -16.65 -15.66 -14.87 -16.67 -22 -17.59 -18.74 -25.67 -15.38 -15.45 -11.62 -9.79 -6.09 -2.47
EBITDA
-1.92M -1.84M -1.54M -1.24M -1.8M -2.37M -2.33M -2.03M -2.52M -2.52M -2.32M -2.77M -1.9M -1.95M -1.32M -919.85K -552.39K -192.37K
EBIT
-1.96M -1.89M -1.58M -1.29M -1.85M -2.43M -2.39M -2.3M -2.81M -2.68M -2.43M -2.81M -1.99M -2.07M -1.34M -957.99K -576.07K -233.2K
Depreciation & Amortization
38.35K 51.89K 37.48K 53.57K 53.72K 54.33K 56.32K 270.79K 293.5K 160.34K 68.92K 86.68K 82.56K 68.21K 39.21K 42K 23.67K 40.83K